Karo Pharma Revenue and Competitors

Karo Pharma is a specialty pharma company that develops, markets and sells pharmaceuticals, OTC-products and hospital supplies. With a strong portfolio of well-known brands, the company has a solid position among pharmacies and the health care sector in the region. Our vision is to become a leading specialty pharma company. Our goal is to achieve greater shareholder value through organic growth and acquisitions, maintaining a solid profit margin. During recent years Karo Pharma has grown rapidly via strategic acquisitions of companies and brands with an established position on the market or with a short time to market. We aim at keeping a lean organization with high competence and efficiency. In 2017 Karo Pharma acquired Weifa, a leading OTC- and pharmaceutical company in Norway. In April 2018 Karo Pharma acquired a product portfolio with an annual turnover of around 700 MSEK from the Danish pharmaceutical company LEO Pharma A/S Karo Pharma is listed on the Nasdaq Stockholm Mid Cap list (karo.st) and the headquarter is located in Stockholm. Our Products and Brands: Pain/fever: Paracet, Ibux, Proxan, Fanalgin Cold: Dexyl, Tussin, Nazamér, Bronkyl, Solvivo Wounds: Pyrisept, Pyricare, Adelli Prescription drugs: Molllipect, Laxabon, Lithionit, Paraflex, Zonat, Paralgin Forte, Samin, Conotrane, Fonx, Condyline, Synalar, Mildison, Centyl, Kaleorid, Burinex and Selexid and more Mabs - CE-marked compression stockings (www.mabs.se) Allévo - healthy products for weight control (www.allevo.nu) Swereco - medical devices and hospital supplies (www.swereco.se) BabySlide - helps prevent ruptures during child birth (www.babyslide.com) Dosett - correct medicine dosage (www.dosett.com) Locobase - Nr. 1 skincare band at Swedish pharmacies (www.locobase.se) Other Brands: Complete, Vagisan, Plantur, Slicks, Zippy, Triolif, Asan and more